QUOTE AND NEWS
SeekingAlpha  Jul 30  Comment 
GenEng News  Jun 23  Comment 
Vical has acknowledged that both the monovalent and bivalent forms of its genital herpes vaccine candidate missed their primary endpoints in a Phase I/II trial, based on topline results. The monovalent and bivalent vaccines—both formulated...
TheStreet.com  Jun 2  Comment 
NEW YORK (TheStreet) -- Vical shares are gaining, up 15.9% to $1.02, on heavy volume trading Tuesday after the biopharmaceutical company had coverage initiated with a "buy" rating by analysts at Roth Capital today.The San Diego-based company...
Benzinga  May 8  Comment 
Vical Incorporated (NASDAQ: VICL) reported a narrower-than-expected loss for the first quarter on Friday. The San Diego, California-based company posted a quarterly loss of $3.8 million, or $0.04 per share, versus a year-ago loss of $3.5...
Benzinga  Dec 11  Comment 
Vical Incorporated (Nasdaq: VICL) today announced the completion of enrollment in a Phase 1/2 trial of its Vaxfectin^®-formulated therapeutic vaccine for herpes simplex virus type 2 (HSV-2), the predominant cause of recurrent genital herpes....





You may also be interested in articles related to Vical (VICL):
 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki